{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T21:32:46Z","timestamp":1792877566972,"version":"4.5.0"},"reference-count":192,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.clineuro.2022.107306","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T21:57:30Z","timestamp":1653515850000},"page":"107306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Shared pathophysiology: Understanding stroke and Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"218","author":[{"given":"Sai","family":"Sriram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf","family":"Mehkri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Quintin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Lucke-Wold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2022.107306_bib1","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.2147\/NDT.S67184","article-title":"Cognitive impairment and memory dysfunction after a stroke diagnosis: a post-stroke memory assessment","volume":"10","author":"Al-Qazzaz","year":"2014","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"6","key":"10.1016\/j.clineuro.2022.107306_bib2","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jalz.2010.04.003","article-title":"Predicting cognitive decline in Alzheimer's disease: an integrated analysis","volume":"6","author":"Lopez","year":"2010","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.clineuro.2022.107306_bib3","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3389\/fnagi.2018.00118","article-title":"The physiological roles of amyloid-beta peptide hint at new ways to treat Alzheimer\u2019s disease","volume":"10","author":"Brothers","year":"2018","journal-title":"Front Aging Neurosci."},{"issue":"12","key":"10.1016\/j.clineuro.2022.107306_bib4","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1001\/archneur.60.12.1707","article-title":"Stroke and the risk of Alzheimer disease","volume":"60","author":"Honig","year":"2003","journal-title":"Arch. Neurol."},{"issue":"8","key":"10.1016\/j.clineuro.2022.107306_bib5","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart disease and stroke statistics-2021 update: a report from the American heart association","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.clineuro.2022.107306_bib6","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S1474-4422(05)70201-5","article-title":"The recognition of stroke in the emergency room (ROSIER) scale: development and validation of a stroke recognition instrument","volume":"4","author":"Nor","year":"2005","journal-title":"Lancet Neurol."},{"issue":"12","key":"10.1016\/j.clineuro.2022.107306_bib7","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.clineuro.2022.107306_bib8","first-page":"33","article-title":"Acute stroke diagnosis","volume":"80","author":"Yew","year":"2009","journal-title":"Am. Fam. Physician"},{"issue":"5","key":"10.1016\/j.clineuro.2022.107306_bib9","doi-asserted-by":"crossref","DOI":"10.3171\/2016.2.FOCUS15637","article-title":"Neurorestoration after stroke","volume":"40","author":"Azad","year":"2016","journal-title":"Neurosurg. Focus"},{"issue":"10029","key":"10.1016\/j.clineuro.2022.107306_bib10","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/S0140-6736(16)00163-X","article-title":"Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials","volume":"387","author":"Goyal","year":"2016","journal-title":"Lancet"},{"issue":"5054","key":"10.1016\/j.clineuro.2022.107306_bib11","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.clineuro.2022.107306_bib12","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1161\/STROKEAHA.112.657759","article-title":"Spectrum of transient focal neurological episodes in cerebral amyloid angiopathy: multicentre magnetic resonance imaging cohort study and meta-analysis","volume":"43","author":"Charidimou","year":"2012","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.clineuro.2022.107306_bib13","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1523\/JNEUROSCI.21-05-01619.2001","article-title":"Spontaneous hemorrhagic stroke in a mouse model of cerebral amyloid angiopathy","volume":"21","author":"Winkler","year":"2001","journal-title":"J. Neurosci."},{"issue":"10","key":"10.1016\/j.clineuro.2022.107306_bib14","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s00702-004-0274-0","article-title":"Circulating beta amyloid protein is elevated in patients with acute ischemic stroke","volume":"112","author":"Lee","year":"2005","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.clineuro.2022.107306_bib15","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.brainres.2010.10.008","article-title":"Triflusal reduces cerebral ischemia induced inflammation in a combined mouse model of Alzheimer\u2019s disease and stroke","volume":"1366","author":"Whitehead","year":"2010","journal-title":"Brain Res."},{"issue":"12","key":"10.1016\/j.clineuro.2022.107306_bib16","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1161\/STROKEAHA.107.492660","article-title":"Progressive increase in infarct size, neuroinflammation, and cognitive deficits in the presence of high levels of amyloid","volume":"38","author":"Whitehead","year":"2007","journal-title":"Stroke"},{"issue":"7806","key":"10.1016\/j.clineuro.2022.107306_bib17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","article-title":"APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline","volume":"581","author":"Montagne","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.clineuro.2022.107306_bib18","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neurobiolaging.2018.06.004","article-title":"The effects of cerebral amyloid angiopathy on integrity of the blood-brain barrier","volume":"70","author":"Magaki","year":"2018","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.clineuro.2022.107306_bib19","doi-asserted-by":"crossref","first-page":"C343","DOI":"10.1152\/ajpcell.00095.2018","article-title":"Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection","volume":"315","author":"Abdullahi","year":"2018","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.clineuro.2022.107306_bib20","article-title":"Cerebral amyloid angiopathy and blood-brain barrier dysfunction","author":"Gireud-Goss","year":"2020","journal-title":"Neuroscientist"},{"key":"10.1016\/j.clineuro.2022.107306_bib21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bbi.2018.07.017","article-title":"The concerted amyloid-beta clearance of LRP1 and ABCB1\/P-gp across the blood-brain barrier is linked by PICALM","volume":"73","author":"Storck","year":"2018","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.clineuro.2022.107306_bib22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1172\/JCI81108","article-title":"Endothelial LRP1 transports amyloid-beta(1-42) across the blood-brain barrier","volume":"126","author":"Storck","year":"2016","journal-title":"J. Clin. Investig."},{"issue":"10","key":"10.1016\/j.clineuro.2022.107306_bib23","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/jcbfm.2013.135","article-title":"Blood-brain barrier dysfunction as a cause and consequence of Alzheimer\u2019s disease","volume":"33","author":"Erickson","year":"2013","journal-title":"J. Cereb. Blood Flow. Metab."},{"issue":"8","key":"10.1016\/j.clineuro.2022.107306_bib24","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1182\/blood-2006-08-043125","article-title":"Tissue-type plasminogen activator-mediated shedding of astrocytic low-density lipoprotein receptor-related protein increases the permeability of the neurovascular unit","volume":"109","author":"Polavarapu","year":"2007","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.clineuro.2022.107306_bib25","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1081\/DMR-120026871","article-title":"Clinical relevance of P-glycoprotein in drug therapy","volume":"35","author":"Lin","year":"2003","journal-title":"Drug Metab. Rev."},{"issue":"7","key":"10.1016\/j.clineuro.2022.107306_bib26","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00008571-200210000-00005","article-title":"Deposition of Alzheimer\u2019s beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans","volume":"12","author":"Vogelgesang","year":"2002","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.clineuro.2022.107306_bib27","doi-asserted-by":"crossref","DOI":"10.1177\/1179069517701741","article-title":"Spatiotemporal changes in P-glycoprotein levels in brain and peripheral tissues following ischemic stroke in rats","volume":"11","author":"DeMars","year":"2017","journal-title":"J. Exp. Neurosci."},{"issue":"2","key":"10.1016\/j.clineuro.2022.107306_bib28","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2990.2008.00966.x","article-title":"The expression of P-glycoprotein is increased in vessels with blood-brain barrier impairment in a stroke-prone hypertensive model","volume":"35","author":"Ueno","year":"2009","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"5123","key":"10.1016\/j.clineuro.2022.107306_bib29","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.clineuro.2022.107306_bib30","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/WAD.0000000000000173","article-title":"Role of APOE epsilon4 Allele and incident stroke on cognitive decline and mortality","volume":"30","author":"Rajan","year":"2016","journal-title":"Alzheimer Dis. Assoc. Disord."},{"issue":"3","key":"10.1016\/j.clineuro.2022.107306_bib31","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00401-013-1145-2","article-title":"Interstitial fluid drainage is impaired in ischemic stroke and Alzheimer\u2019s disease mouse models","volume":"126","author":"Arbel-Ornath","year":"2013","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.clineuro.2022.107306_bib32","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s40478-021-01274-8","article-title":"The alpha-dystrobrevins play a key role in maintaining the structure and function of the extracellular matrix-significance for protein elimination failure arteriopathies","volume":"9","author":"Sharp","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"issue":"4","key":"10.1016\/j.clineuro.2022.107306_bib33","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.neuron.2013.04.014","article-title":"Alzheimer\u2019s disease risk gene CD33 inhibits microglial uptake of amyloid beta","volume":"78","author":"Griciuc","year":"2013","journal-title":"Neuron"},{"issue":"17","key":"10.1016\/j.clineuro.2022.107306_bib34","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1093\/hmg\/ddaa179","article-title":"Gene therapy for Alzheimer\u2019s disease targeting CD33 reduces amyloid beta accumulation and neuroinflammation","volume":"29","author":"Griciuc","year":"2020","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"10.1016\/j.clineuro.2022.107306_bib35","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1161\/STROKEAHA.107.498212","article-title":"Toll-like receptor 4 is involved in subacute stress-induced neuroinflammation and in the worsening of experimental stroke","volume":"39","author":"Caso","year":"2008","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.clineuro.2022.107306_bib36","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.neuron.2017.05.037","article-title":"TDP-43 depletion in microglia promotes amyloid clearance but also induces synapse loss","volume":"95","author":"Paolicelli","year":"2017","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.clineuro.2022.107306_bib37","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/(SICI)1097-4547(19960115)43:2<190::AID-JNR7>3.0.CO;2-B","article-title":"Scavenging of Alzheimer\u2019s amyloid beta-protein by microglia in culture","volume":"43","author":"Ard","year":"1996","journal-title":"J. Neurosci. Res"},{"issue":"10","key":"10.1016\/j.clineuro.2022.107306_bib38","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1091\/mbc.e10-09-0745","article-title":"Degradation of Alzheimer\u2019s amyloid fibrils by microglia requires delivery of ClC-7 to lysosomes","volume":"22","author":"Majumdar","year":"2011","journal-title":"Mol. Biol. Cell"},{"issue":"12","key":"10.1016\/j.clineuro.2022.107306_bib39","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1002\/jcp.22675","article-title":"Amyloid-beta-induced reactive oxygen species production and priming are differentially regulated by ion channels in microglia","volume":"226","author":"Schilling","year":"2011","journal-title":"J. Cell Physiol."},{"issue":"22","key":"10.1016\/j.clineuro.2022.107306_bib40","doi-asserted-by":"crossref","first-page":"15493","DOI":"10.1074\/jbc.274.22.15493","article-title":"beta-amyloid activates the O-2 forming NADPH oxidase in microglia, monocytes, and neutrophils. A possible inflammatory mechanism of neuronal damage in Alzheimer\u2019s disease","volume":"274","author":"Bianca","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.clineuro.2022.107306_bib41","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0002-9440(10)64085-0","article-title":"Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer\u2019s disease","volume":"158","author":"Matsuoka","year":"2001","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.clineuro.2022.107306_bib42","first-page":"313","article-title":"Amyloid-beta peptide induced inflammatory reaction is mediated by the cytokines tumor necrosis factor and interleukin-1","volume":"31","author":"Sutton","year":"1999","journal-title":"J. Submicrosc. Cytol. Pathol."},{"issue":"43","key":"10.1016\/j.clineuro.2022.107306_bib43","doi-asserted-by":"crossref","first-page":"13435","DOI":"10.1523\/JNEUROSCI.3257-09.2009","article-title":"Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord","volume":"29","author":"Kigerl","year":"2009","journal-title":"J. Neurosci."},{"issue":"11","key":"10.1016\/j.clineuro.2022.107306_bib44","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1161\/STROKEAHA.112.659656","article-title":"Microglia\/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia","volume":"43","author":"Hu","year":"2012","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.clineuro.2022.107306_bib45","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ejca.2006.01.003","article-title":"Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy","volume":"42","author":"Sica","year":"2006","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.clineuro.2022.107306_bib46","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1742-2094-11-98","article-title":"Neuroinflammation and M2 microglia: the good, the bad, and the inflamed","volume":"11","author":"Cherry","year":"2014","journal-title":"J. Neuroinflamm."},{"issue":"6","key":"10.1016\/j.clineuro.2022.107306_bib47","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1021\/acschemneuro.9b00651","article-title":"Compound AD110 acts as therapeutic management for alzheimer\u2019s disease and stroke in mouse and rat models","volume":"11","author":"Sun","year":"2020","journal-title":"ACS Chem. Neurosci."},{"issue":"10","key":"10.1016\/j.clineuro.2022.107306_bib48","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jamaneurol.2020.1782","article-title":"Association between immunosuppressive treatment and outcomes of cerebral amyloid angiopathy-related inflammation","volume":"77","author":"Regenhardt","year":"2020","journal-title":"JAMA Neurol."},{"issue":"8","key":"10.1016\/j.clineuro.2022.107306_bib49","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1096\/fj.201600435RR","article-title":"Regulation of brain endothelial barrier function by microRNAs in health and neuroinflammation","volume":"30","author":"Lopez-Ramirez","year":"2016","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.clineuro.2022.107306_bib50","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/00207454.2020.1738428","article-title":"MiRNA: a potential target for gene diagnosis and treatment of atherosclerotic stroke","volume":"131","author":"Bao","year":"2021","journal-title":"Int. J. Neurosci."},{"issue":"Pt 6","key":"10.1016\/j.clineuro.2022.107306_bib51","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1042\/BST0361224","article-title":"How do microRNAs regulate gene expression?","volume":"36","author":"Cannell","year":"2008","journal-title":"Biochem. Soc. Trans."},{"issue":"1","key":"10.1016\/j.clineuro.2022.107306_bib52","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1523\/JNEUROSCI.1348-17.2017","article-title":"Circular RNA DLGAP4 ameliorates ischemic stroke outcomes by targeting miR-143 to regulate endothelial-mesenchymal transition associated with blood-brain barrier integrity","volume":"38","author":"Bai","year":"2018","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.clineuro.2022.107306_bib53","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1161\/STROKEAHA.118.023648","article-title":"Serum MicroRNA-based risk prediction for stroke","volume":"50","author":"Sonoda","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.clineuro.2022.107306_bib54","doi-asserted-by":"crossref","first-page":"35659","DOI":"10.1038\/srep35659","article-title":"Oxytocin modulates GABAAR subunits to confer neuroprotection in stroke in vitro","volume":"6","author":"Kaneko","year":"2016","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.clineuro.2022.107306_bib55","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1161\/STROKEAHA.115.012079","article-title":"Interleukin-4 is essential for microglia\/macrophage M2 polarization and long-term recovery after cerebral ischemia","volume":"47","author":"Liu","year":"2016","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.clineuro.2022.107306_bib56","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/CIRCRESAHA.120.317596","article-title":"tPA mobilizes immune cells that exacerbate hemorrhagic transformation in stroke","volume":"128","author":"Shi","year":"2021","journal-title":"Circ. Res."},{"issue":"12","key":"10.1016\/j.clineuro.2022.107306_bib57","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nrneurol.2013.223","article-title":"Alzheimer disease therapy--moving from amyloid-beta to tau","volume":"9","author":"Giacobini","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.clineuro.2022.107306_bib58","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3389\/fneur.2013.00112","article-title":"Hyperphosphorylation-induced tau oligomers","volume":"4","author":"Iqbal","year":"2013","journal-title":"Front. Neurol."},{"issue":"2","key":"10.1016\/j.clineuro.2022.107306_bib59","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/jnc.12621","article-title":"Microtubules in neurons as information carriers","volume":"129","author":"Dent","year":"2014","journal-title":"J. Neurochem."},{"issue":"9","key":"10.1016\/j.clineuro.2022.107306_bib60","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nrn2194","article-title":"Tau-mediated neurodegeneration in Alzheimer\u2019s disease and related disorders","volume":"8","author":"Ballatore","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.clineuro.2022.107306_bib61","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.ijbiomac.2020.07.327","article-title":"Role of tau protein in Alzheimer\u2019s disease: the prime pathological player","volume":"163","author":"Muralidar","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.clineuro.2022.107306_bib62","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1749-8104-8-17","article-title":"The intricate relationship between microtubules and their associated motor proteins during axon growth and maintenance","volume":"8","author":"Prokop","year":"2013","journal-title":"Neural Dev."},{"issue":"5733","key":"10.1016\/j.clineuro.2022.107306_bib63","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1126\/science.1113694","article-title":"Tau suppression in a neurodegenerative mouse model improves memory function","volume":"309","author":"Santacruz","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.clineuro.2022.107306_bib64","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fnagi.2017.00083","article-title":"Tau oligomers: cytotoxicity, propagation, and mitochondrial damage","volume":"9","author":"Shafiei","year":"2017","journal-title":"Front. Aging Neurosci."},{"issue":"4","key":"10.1016\/j.clineuro.2022.107306_bib65","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","article-title":"Amyloid-beta and tau: the trigger and bullet in Alzheimer disease pathogenesis","volume":"71","author":"Bloom","year":"2014","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.clineuro.2022.107306_bib66","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41583-019-0240-3","article-title":"Amyloid-beta-independent regulators of tau pathology in Alzheimer disease","volume":"21","author":"van der Kant","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.clineuro.2022.107306_bib67","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fncel.2020.00051","article-title":"Ischemia-triggered glutamate excitotoxicity from the perspective of glial cells","volume":"14","author":"Belov Kirdajova","year":"2020","journal-title":"Front. Cell Neurosci."},{"issue":"1","key":"10.1016\/j.clineuro.2022.107306_bib68","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41467-017-00618-0","article-title":"Tau exacerbates excitotoxic brain damage in an animal model of stroke","volume":"8","author":"Bi","year":"2017","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.clineuro.2022.107306_bib69","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1038\/mp.2017.171","article-title":"Tau-mediated iron export prevents ferroptotic damage after ischemic stroke","volume":"22","author":"Tuo","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.clineuro.2022.107306_bib70","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.bbi.2016.09.027","article-title":"Does neuroinflammation drive the relationship between tau hyperphosphorylation and dementia development following traumatic brain injury?","volume":"60","author":"Collins-Praino","year":"2017","journal-title":"Brain Behav. Immun."},{"issue":"7","key":"10.1016\/j.clineuro.2022.107306_bib71","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer\u2019s disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.clineuro.2022.107306_bib72","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jalz.2011.03.004","article-title":"Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Jack","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.clineuro.2022.107306_bib73","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3389\/fnins.2017.00281","article-title":"Time to amyloid positivity and preclinical changes in brain metabolism, atrophy, and cognition: evidence for emerging amyloid pathology in Alzheimer\u2019s Disease","volume":"11","author":"Insel","year":"2017","journal-title":"Front. Neurosci."},{"issue":"6","key":"10.1016\/j.clineuro.2022.107306_bib74","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/alzrt222","article-title":"Promising developments in neuropsychological approaches for the detection of preclinical Alzheimer\u2019s disease: a selective review","volume":"5","author":"Rentz","year":"2013","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.clineuro.2022.107306_bib75","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.dadm.2016.03.004","article-title":"Progression and predictors of mild cognitive impairment in Chinese elderly: a prospective follow-up in the Shanghai Aging Study","volume":"4","author":"Ding","year":"2016","journal-title":"Alzheimers Dement (Amst. )"},{"issue":"3","key":"10.1016\/j.clineuro.2022.107306_bib76","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"5","key":"10.1016\/j.clineuro.2022.107306_bib77","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jalz.2011.05.2410","article-title":"Neuropsychiatric symptoms in Alzheimer's disease","volume":"7","author":"Lyketsos","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"6","key":"10.1016\/j.clineuro.2022.107306_bib78","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer\u2019s disease: the IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol."},{"issue":"24","key":"10.1016\/j.clineuro.2022.107306_bib79","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25245789","article-title":"Comprehensive review on Alzheimer\u2019s disease: causes and treatment","volume":"25","author":"Breijyeh","year":"2020","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.clineuro.2022.107306_bib80","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S1474-4422(21)00066-1","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: recommendations of the International Working Group","volume":"20","author":"Dubois","year":"2021","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.clineuro.2022.107306_bib81","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3233\/JAD-180766","article-title":"Treatment combinations for Alzheimer\u2019s disease: current and future pharmacotherapy options","volume":"67","author":"Cummings","year":"2019","journal-title":"J. Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.clineuro.2022.107306_bib82","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7861\/clinmedicine.16-3-247","article-title":"Drug treatments in Alzheimer\u2019s disease","volume":"16","author":"Briggs","year":"2016","journal-title":"Clin. Med (Lond. )"},{"key":"10.1016\/j.clineuro.2022.107306_bib83","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003154","article-title":"Memantine for dementia","volume":"3","author":"Areosa","year":"2003","journal-title":"Cochrane Database Syst. Rev."},{"issue":"4","key":"10.1016\/j.clineuro.2022.107306_bib84","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1358\/dot.2016.52.4.2479357","article-title":"Memantine and donepezil: a fixed drug combination for the treatment of moderate to severe Alzheimer\u2019s dementia","volume":"52","author":"Owen","year":"2016","journal-title":"Drugs Today (Barc. )"},{"issue":"18","key":"10.1016\/j.clineuro.2022.107306_bib85","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1706441","article-title":"Randomized trial of verubecestat for mild-to-moderate Alzheimer\u2019s disease","volume":"378","author":"Egan","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.clineuro.2022.107306_bib86","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1210951","article-title":"A phase 3 trial of semagacestat for treatment of Alzheimer\u2019s disease","volume":"369","author":"Doody","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.clineuro.2022.107306_bib87","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1001\/jamaneurol.2015.0607","article-title":"Targeting prodromal alzheimer disease with avagacestat: a randomized clinical trial","volume":"72","author":"Coric","year":"2015","journal-title":"JAMA Neurol."},{"issue":"7618","key":"10.1016\/j.clineuro.2022.107306_bib88","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces Abeta plaques in Alzheimer\u2019s disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.clineuro.2022.107306_bib89","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1001\/jamainternmed.2021.4607","article-title":"Approval of Aducanumab for Alzheimer disease-the FDA\u2019s perspective","volume":"181","author":"Dunn","year":"2021","journal-title":"JAMA Intern. Med."},{"issue":"1","key":"10.1016\/j.clineuro.2022.107306_bib90","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13195-017-0318-y","article-title":"A phase III randomized trial of gantenerumab in prodromal Alzheimer\u2019s disease","volume":"9","author":"Ostrowitzki","year":"2017","journal-title":"Alzheimers Res. Ther."},{"issue":"1","key":"10.1016\/j.clineuro.2022.107306_bib91","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13195-020-0580-2","article-title":"Pharmacokinetics and pharmacodynamic effect of crenezumab on plasma and cerebrospinal fluid beta-amyloid in patients with mild-to-moderate Alzheimer\u2019s disease","volume":"12","author":"Yoshida","year":"2020","journal-title":"Alzheimers Res. Ther."},{"issue":"2","key":"10.1016\/j.clineuro.2022.107306_bib92","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/ana.25513","article-title":"Target engagement in an alzheimer trial: Crenezumab lowers amyloid beta oligomers in cerebrospinal fluid","volume":"86","author":"Yang","year":"2019","journal-title":"Ann. Neurol."},{"issue":"9634","key":"10.1016\/j.clineuro.2022.107306_bib93","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0140-6736(08)61075-2","article-title":"Long-term effects of Abeta42 immunisation in Alzheimer\u2019s disease: follow-up of a randomised, placebo-controlled phase I trial","volume":"372","author":"Holmes","year":"2008","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.clineuro.2022.107306_bib94","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1474-4422(12)70140-0","article-title":"Safety, tolerability, and antibody response of active Abeta immunotherapy with CAD106 in patients with Alzheimer\u2019s disease: randomised, double-blind, placebo-controlled, first-in-human study","volume":"11","author":"Winblad","year":"2012","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.clineuro.2022.107306_bib95","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12929-017-0355-7","article-title":"Drug candidates in clinical trials for Alzheimer\u2019s disease","volume":"24","author":"Hung","year":"2017","journal-title":"J. Biomed. Sci."},{"issue":"3","key":"10.1016\/j.clineuro.2022.107306_bib96","doi-asserted-by":"crossref","first-page":"242","DOI":"10.2174\/1567205012666150302154121","article-title":"Vanutide cridificar and the QS-21 adjuvant in Japanese subjects with mild to moderate Alzheimer\u2019s disease: results from two phase 2 studies","volume":"12","author":"Arai","year":"2015","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.clineuro.2022.107306_bib97","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3389\/fnins.2017.00572","article-title":"Axonal degeneration in tauopathies: disease relevance and underlying mechanisms","volume":"11","author":"Kneynsberg","year":"2017","journal-title":"Front Neurosci."},{"issue":"1","key":"10.1016\/j.clineuro.2022.107306_bib98","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1124\/jpet.107.130526","article-title":"A neuronal microtubule-interacting agent, NAPVSIPQ, reduces tau pathology and enhances cognitive function in a mouse model of Alzheimer\u2019s disease","volume":"325","author":"Matsuoka","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"7","key":"10.1016\/j.clineuro.2022.107306_bib99","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S1474-4422(14)70088-2","article-title":"Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2\/3 trial","volume":"13","author":"Boxer","year":"2014","journal-title":"Lancet Neurol."},{"issue":"41","key":"10.1016\/j.clineuro.2022.107306_bib100","doi-asserted-by":"crossref","first-page":"13861","DOI":"10.1523\/JNEUROSCI.3059-10.2010","article-title":"Epothilone D improves microtubule density, axonal integrity, and cognition in a transgenic mouse model of tauopathy","volume":"30","author":"Brunden","year":"2010","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.clineuro.2022.107306_bib101","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19041160","article-title":"An overview on the clinical development of tau-based therapeutics","volume":"19","author":"Medina","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.clineuro.2022.107306_bib102","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3233\/JAD-142874","article-title":"Tau aggregation inhibitor therapy: an exploratory phase 2 study in mild or moderate Alzheimer\u2019s disease","volume":"44","author":"Wischik","year":"2015","journal-title":"J. Alzheimers Dis."},{"issue":"4","key":"10.1016\/j.clineuro.2022.107306_bib103","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1471-4159.2011.07337.x","article-title":"Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain","volume":"118","author":"Boutajangout","year":"2011","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.clineuro.2022.107306_bib104","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/alzrt278","article-title":"First-in-man tau vaccine targeting structural determinants essential for pathological tau-tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer\u2019s disease model","volume":"6","author":"Kontsekova","year":"2014","journal-title":"Alzheimers Res. Ther."},{"issue":"3","key":"10.1016\/j.clineuro.2022.107306_bib105","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1053\/j.jvca.2020.07.058","article-title":"Ultrasound-guided pecto-intercostal fascial block for postoperative pain management in cardiac surgery: a prospective, randomized, placebo-controlled trial","volume":"35","author":"Khera","year":"2021","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"issue":"3","key":"10.1016\/j.clineuro.2022.107306_bib106","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S1474-4422(20)30489-0","article-title":"Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial","volume":"20","author":"Hoglinger","year":"2021","journal-title":"Lancet Neurol."},{"issue":"593","key":"10.1016\/j.clineuro.2022.107306_bib107","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb2639","article-title":"Antibody semorinemab reduces tau pathology in a transgenic mouse model and engages tau in patients with Alzheimer\u2019s disease","volume":"13","author":"Ayalon","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"7","key":"10.1016\/j.clineuro.2022.107306_bib108","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","article-title":"Tau-targeting therapies for Alzheimer disease","volume":"14","author":"Congdon","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.clineuro.2022.107306_bib109","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.590896","article-title":"New insights into drug discovery targeting tau protein","volume":"13","author":"Soeda","year":"2020","journal-title":"Front. Mol. Neurosci."},{"issue":"374","key":"10.1016\/j.clineuro.2022.107306_bib110","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag0481","article-title":"Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy","volume":"9","author":"DeVos","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.clineuro.2022.107306_bib111","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/jnc.14615","article-title":"In vivo molecular imaging of neuroinflammation in Alzheimer\u2019s disease","volume":"149","author":"Chaney","year":"2019","journal-title":"J. Neurochem."},{"key":"10.1016\/j.clineuro.2022.107306_bib112","doi-asserted-by":"crossref","DOI":"10.1177\/1756286418791107","article-title":"Can inflammation be resolved in Alzheimer\u2019s disease?","volume":"11","author":"Zhu","year":"2018","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.clineuro.2022.107306_bib113","doi-asserted-by":"crossref","first-page":"a1198","DOI":"10.1136\/bmj.a1198","article-title":"Low dose aspirin and cognitive function in middle aged to elderly adults: randomised controlled trial","volume":"337","author":"Price","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.clineuro.2022.107306_bib114","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.clinbiochem.2019.04.001","article-title":"Neuro-inflammation and anti-inflammatory treatment options for Alzheimer\u2019s disease","volume":"72","author":"Ozben","year":"2019","journal-title":"Clin. Biochem."},{"issue":"4","key":"10.1016\/j.clineuro.2022.107306_bib115","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2217\/nmt-2021-0019","article-title":"Masitinib for the treatment of Alzheimer\u2019s disease","volume":"11","author":"Ettcheto","year":"2021","journal-title":"Neurodegener. Dis. Manag."},{"issue":"24","key":"10.1016\/j.clineuro.2022.107306_bib116","doi-asserted-by":"crossref","first-page":"13287","DOI":"10.1073\/pnas.94.24.13287","article-title":"Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology","volume":"94","author":"Sturchler-Pierrat","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5284","key":"10.1016\/j.clineuro.2022.107306_bib117","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.274.5284.99","article-title":"Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice","volume":"274","author":"Hsiao","year":"1996","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.clineuro.2022.107306_bib118","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nn.3697","article-title":"Single App knock-in mouse models of Alzheimer\u2019s disease","volume":"17","author":"Saito","year":"2014","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.clineuro.2022.107306_bib119","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1038\/s41467-021-22624-z","article-title":"Generation of a humanized Abeta expressing mouse demonstrating aspects of Alzheimer\u2019s disease-like pathology","volume":"12","author":"Baglietto-Vargas","year":"2021","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.clineuro.2022.107306_bib120","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1016\/j.neurobiolaging.2015.06.028","article-title":"Cerebral amyloid angiopathy and its co-occurrence with Alzheimer\u2019s disease and other cerebrovascular neuropathologic changes","volume":"36","author":"Brenowitz","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.clineuro.2022.107306_bib121","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3389\/fneur.2019.00391","article-title":"Beta amyloid deposition is not associated with cognitive impairment in Parkinson\u2019s disease","volume":"10","author":"Melzer","year":"2019","journal-title":"Front. Neurol."},{"issue":"4","key":"10.1016\/j.clineuro.2022.107306_bib122","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s12975-019-00755-2","article-title":"From stroke to dementia: a comprehensive review exposing tight interactions between stroke and amyloid-beta formation","volume":"11","author":"Goulay","year":"2020","journal-title":"Transl. Stroke Res."},{"issue":"1","key":"10.1016\/j.clineuro.2022.107306_bib123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cercor\/bhaa184","article-title":"Spatial relationships between molecular pathology and neurodegeneration in the Alzheimer\u2019s disease continuum","volume":"31","author":"Iaccarino","year":"2021","journal-title":"Cereb. Cortex"},{"issue":"4","key":"10.1016\/j.clineuro.2022.107306_bib124","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/bpa.12152","article-title":"The pericyte: a forgotten cell type with important implications for Alzheimer\u2019s disease?","volume":"24","author":"Winkler","year":"2014","journal-title":"Brain Pathol."},{"issue":"10","key":"10.1016\/j.clineuro.2022.107306_bib125","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/s41419-020-03020-9","article-title":"Intracellular amyloid toxicity induces oxytosis\/ferroptosis regulated cell death","volume":"11","author":"Huang","year":"2020","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.clineuro.2022.107306_bib126","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12974-019-1399-2","article-title":"Glial activation and inflammation along the Alzheimer\u2019s disease continuum","volume":"16","author":"Nordengen","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.clineuro.2022.107306_bib127","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.mcn.2018.03.015","article-title":"Abeta-oligomer uptake and the resulting inflammatory response in adult human astrocytes are precluded by an anti-Abeta single chain variable fragment in combination with an apoE mimetic peptide","volume":"89","author":"Montoliu-Gaya","year":"2018","journal-title":"Mol. Cell Neurosci."},{"issue":"7321","key":"10.1016\/j.clineuro.2022.107306_bib128","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nature09613","article-title":"Glial and neuronal control of brain blood flow","volume":"468","author":"Attwell","year":"2010","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.clineuro.2022.107306_bib129","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","article-title":"Clearance systems in the brain-implications for Alzheimer disease","volume":"11","author":"Tarasoff-Conway","year":"2015","journal-title":"Nat. Rev. Neurol."},{"issue":"6","key":"10.1016\/j.clineuro.2022.107306_bib130","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.immuni.2017.06.006","article-title":"Reactive astrocytes: production, function, and therapeutic potential","volume":"46","author":"Liddelow","year":"2017","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.clineuro.2022.107306_bib131","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci10080503","article-title":"The increased densities, but different distributions, of both C3 and S100A10 immunopositive astrocyte-like cells in Alzheimer\u2019s disease brains suggest possible roles for both A1 and A2 astrocytes in the disease pathogenesis","volume":"10","author":"King","year":"2020","journal-title":"Brain Sci."},{"issue":"7638","key":"10.1016\/j.clineuro.2022.107306_bib132","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.clineuro.2022.107306_bib133","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neurobiolaging.2017.03.021","article-title":"Immune hyperreactivity of Abeta plaque-associated microglia in Alzheimer\u2019s disease","volume":"55","author":"Yin","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.clineuro.2022.107306_bib134","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1742-2094-11-48","article-title":"Microglia receptors and their implications in the response to amyloid beta for Alzheimer\u2019s disease pathogenesis","volume":"11","author":"Doens","year":"2014","journal-title":"J. Neuroinflamm."},{"issue":"4","key":"10.1016\/j.clineuro.2022.107306_bib135","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.nurt.2010.07.005","article-title":"Microglial activation in stroke: therapeutic targets","volume":"7","author":"Yenari","year":"2010","journal-title":"Neurotherapeutics"},{"issue":"Pt 12","key":"10.1016\/j.clineuro.2022.107306_bib136","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1093\/brain\/awr300","article-title":"Cerebrovascular lesions induce transient beta-amyloid deposition","volume":"134","author":"Garcia-Alloza","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.clineuro.2022.107306_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2019.146379","article-title":"Chronic cerebral hypoperfusion alters amyloid-beta transport related proteins in the cortical blood vessels of Alzheimer\u2019s disease model mouse","volume":"1723","author":"Shang","year":"2019","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.clineuro.2022.107306_bib138","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24040687","article-title":"Inhibition of amyloid beta aggregation and deposition of cistanche tubulosa aqueous extract","volume":"24","author":"Chao","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.clineuro.2022.107306_bib139","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12974-015-0304-x","article-title":"Amyloid beta peptide-induced inhibition of endothelial nitric oxide production involves oxidative stress-mediated constitutive eNOS\/HSP90 interaction and disruption of agonist-mediated Akt activation","volume":"12","author":"Lamoke","year":"2015","journal-title":"J. Neuroinflamm."},{"issue":"23","key":"10.1016\/j.clineuro.2022.107306_bib140","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1212\/01.wnl.0000436935.47657.78","article-title":"Pulse pressure is associated with Alzheimer biomarkers in cognitively normal older adults","volume":"81","author":"Nation","year":"2013","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.clineuro.2022.107306_bib141","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0304-3940(02)00589-X","article-title":"Beta-amyloid-associated expression of intercellular adhesion molecule-1 in brain cortical tissue of transgenic Tg2576 mice","volume":"329","author":"Apelt","year":"2002","journal-title":"Neurosci. Lett."},{"issue":"7323","key":"10.1016\/j.clineuro.2022.107306_bib142","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature09522","article-title":"Pericytes regulate the blood-brain barrier","volume":"468","author":"Armulik","year":"2010","journal-title":"Nature"},{"issue":"1\u20132","key":"10.1016\/j.clineuro.2022.107306_bib143","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jns.2012.07.010","article-title":"The vascular factor in Alzheimer\u2019s disease: a study in Golgi technique and electron microscopy","volume":"322","author":"Baloyannis","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.clineuro.2022.107306_bib144","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1038\/ncomms3932","article-title":"Pericyte loss influences Alzheimer-like neurodegeneration in mice","volume":"4","author":"Sagare","year":"2013","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.clineuro.2022.107306_bib145","doi-asserted-by":"crossref","first-page":"H550","DOI":"10.1152\/ajpheart.00183.2018","article-title":"No-reflow phenomenon in the heart and brain","volume":"315","author":"Kloner","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"8","key":"10.1016\/j.clineuro.2022.107306_bib146","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/ejhg.2008.27","article-title":"Associations of apolipoprotein E gene with ischemic stroke and intracranial atherosclerosis","volume":"16","author":"Abboud","year":"2008","journal-title":"Eur. J. Hum. Genet"},{"issue":"1","key":"10.1016\/j.clineuro.2022.107306_bib147","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13041-021-00803-9","article-title":"APOE genotype dependent molecular abnormalities in the cerebrovasculature of Alzheimer\u2019s disease and age-matched non-demented brains","volume":"14","author":"Ojo","year":"2021","journal-title":"Mol. Brain"},{"key":"10.1016\/j.clineuro.2022.107306_bib148","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2016.07.007","article-title":"The blood-brain barrier in Alzheimer\u2019s disease","volume":"107","author":"Zenaro","year":"2017","journal-title":"Neurobiol. Dis."},{"issue":"10","key":"10.1016\/j.clineuro.2022.107306_bib149","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1161\/STROKEAHA.114.006617","article-title":"Impaired glymphatic perfusion after strokes revealed by contrast-enhanced MRI: a new target for fibrinolysis?","volume":"45","author":"Gaberel","year":"2014","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.clineuro.2022.107306_bib150","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3233\/JAD-2011-102034","article-title":"Dendritic cells regulate amyloid-beta-specific T-cell entry into the brain: the role of perivascular amyloid-beta","volume":"27","author":"Fisher","year":"2011","journal-title":"J. Alzheimers Dis."},{"issue":"44","key":"10.1016\/j.clineuro.2022.107306_bib151","doi-asserted-by":"crossref","first-page":"11437","DOI":"10.1523\/JNEUROSCI.2436-06.2006","article-title":"Increased T cell recruitment to the CNS after amyloid beta 1-42 immunization in Alzheimer\u2019s mice overproducing transforming growth factor-beta 1","volume":"26","author":"Buckwalter","year":"2006","journal-title":"J. Neurosci."},{"issue":"7790","key":"10.1016\/j.clineuro.2022.107306_bib152","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41586-019-1895-7","article-title":"Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer\u2019s disease","volume":"577","author":"Gate","year":"2020","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.clineuro.2022.107306_bib153","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.3233\/JAD-200759","article-title":"Peripheral markers of vascular endothelial dysfunction show independent but additive relationships with brain-based biomarkers in association with functional impairment in Alzheimer\u2019s disease","volume":"80","author":"Drake","year":"2021","journal-title":"J. Alzheimers Dis."},{"issue":"5","key":"10.1016\/j.clineuro.2022.107306_bib154","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1161\/01.CIR.94.5.939","article-title":"Endothelial ICAM-1 expression associated with inflammatory cell response in human ischemic stroke","volume":"94","author":"Lindsberg","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.clineuro.2022.107306_bib155","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3389\/fpsyt.2019.00184","article-title":"Effect of inflammation on the process of stroke rehabilitation and poststroke depression","volume":"10","author":"Fang","year":"2019","journal-title":"Front Psychiatry"},{"issue":"Pt 9","key":"10.1016\/j.clineuro.2022.107306_bib156","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1093\/brain\/awt188","article-title":"Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer\u2019s Coordinating Centre","volume":"136","author":"Toledo","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.clineuro.2022.107306_bib157","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.631770","article-title":"The impact of disease comorbidities in Alzheimer\u2019s disease","volume":"13","author":"Santiago","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.clineuro.2022.107306_bib158","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0169-328X(98)00330-1","article-title":"Activation of nuclear factor-kappaB in the rat brain after transient focal ischemia","volume":"65","author":"Gabriel","year":"1999","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"20","key":"10.1016\/j.clineuro.2022.107306_bib159","doi-asserted-by":"crossref","first-page":"9328","DOI":"10.1073\/pnas.92.20.9328","article-title":"Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation","volume":"92","author":"Barger","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.clineuro.2022.107306_bib160","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/0169-328X(96)00036-8","article-title":"Induction of neuroprotective kappa B-dependent transcription by secreted forms of the Alzheimer\u2019s beta-amyloid precursor","volume":"40","author":"Barger","year":"1996","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"20","key":"10.1016\/j.clineuro.2022.107306_bib161","doi-asserted-by":"crossref","first-page":"9077","DOI":"10.1073\/pnas.92.20.9077","article-title":"Synaptic activation of NF-kappa B by glutamate in cerebellar granule neurons in vitro","volume":"92","author":"Guerrini","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.clineuro.2022.107306_bib162","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1074\/jbc.274.4.2432","article-title":"NF-kappaB activity is induced by neural cell adhesion molecule binding to neurons and astrocytes","volume":"274","author":"Krushel","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"13","key":"10.1016\/j.clineuro.2022.107306_bib163","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1097\/00001756-199709080-00009","article-title":"Nuclear translocation of NF-kappaB in cholinergic neurons of patients with Alzheimer\u2019s disease","volume":"8","author":"Boissiere","year":"1997","journal-title":"Neuroreport"},{"key":"10.1016\/j.clineuro.2022.107306_bib164","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1749-6632.2010.05735.x","article-title":"NF-kappaB and innate immunity in ischemic stroke","volume":"1207","author":"Harari","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"50","key":"10.1016\/j.clineuro.2022.107306_bib165","doi-asserted-by":"crossref","first-page":"12896","DOI":"10.1523\/JNEUROSCI.3670-06.2006","article-title":"Bim and Noxa are candidates to mediate the deleterious effect of the NF-kappa B subunit RelA in cerebral ischemia","volume":"26","author":"Inta","year":"2006","journal-title":"J. Neurosci."},{"issue":"11","key":"10.1016\/j.clineuro.2022.107306_bib166","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1089\/neu.1999.16.1023","article-title":"Prolonged activation of NF-kappaB following traumatic brain injury in rats","volume":"16","author":"Nonaka","year":"1999","journal-title":"J. Neurotrauma"},{"issue":"4","key":"10.1016\/j.clineuro.2022.107306_bib167","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1096\/fj.201700826R","article-title":"IKK2\/NF-kappaB signaling protects neurons after traumatic brain injury","volume":"32","author":"Mettang","year":"2018","journal-title":"FASEB J."},{"key":"10.1016\/j.clineuro.2022.107306_bib168","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/504678","article-title":"The role of oxidative damage in the pathogenesis and progression of Alzheimer\u2019s disease and vascular dementia","volume":"2015","author":"Luca","year":"2015","journal-title":"Oxid. Med. Cell Longev."},{"issue":"1","key":"10.1016\/j.clineuro.2022.107306_bib169","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF02815160","article-title":"Mitochondrial membrane fluidity and oxidative damage to mitochondrial DNA in aged and AD human brain","volume":"31","author":"Mecocci","year":"1997","journal-title":"Mol. Chem. Neuropathol."},{"issue":"1\u20132","key":"10.1016\/j.clineuro.2022.107306_bib170","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0006-8993(99)01409-2","article-title":"Oxidative damage and breakage of DNA in rat brain after transient MCA occlusion","volume":"832","author":"Hayashi","year":"1999","journal-title":"Brain Res."},{"issue":"6994","key":"10.1016\/j.clineuro.2022.107306_bib171","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nature02661","article-title":"Gene regulation and DNA damage in the ageing human brain","volume":"429","author":"Lu","year":"2004","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.clineuro.2022.107306_bib172","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/nn.3460","article-title":"SIRT1 collaborates with ATM and HDAC1 to maintain genomic stability in neurons","volume":"16","author":"Dobbin","year":"2013","journal-title":"Nat. Neurosci."},{"issue":"5","key":"10.1016\/j.clineuro.2022.107306_bib173","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1073\/pnas.0307708100","article-title":"Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1","volume":"101","author":"Gui","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.clineuro.2022.107306_bib174","doi-asserted-by":"crossref","first-page":"806","DOI":"10.4161\/epi.20922","article-title":"Histone deacetylase complexes as caretakers of genome stability","volume":"7","author":"Lahue","year":"2012","journal-title":"Epigenetics"},{"issue":"1","key":"10.1016\/j.clineuro.2022.107306_bib175","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0021-9258(18)48474-8","article-title":"8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G----T and A----C substitutions","volume":"267","author":"Cheng","year":"1992","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.clineuro.2022.107306_bib176","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1038\/s41467-020-16361-y","article-title":"HDAC1 modulates OGG1-initiated oxidative DNA damage repair in the aging brain and Alzheimer\u2019s disease","volume":"11","author":"Pao","year":"2020","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.clineuro.2022.107306_bib177","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/jcbfm.2010.147","article-title":"Evidence that OGG1 glycosylase protects neurons against oxidative DNA damage and cell death under ischemic conditions","volume":"31","author":"Liu","year":"2011","journal-title":"J. Cereb. Blood Flow. Metab."},{"issue":"1","key":"10.1016\/j.clineuro.2022.107306_bib178","doi-asserted-by":"crossref","first-page":"16354","DOI":"10.1038\/s41598-021-95837-3","article-title":"HDAC1 deregulation promotes neuronal loss and deficit of motor function in stroke pathogenesis","volume":"11","author":"Chen","year":"2021","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.clineuro.2022.107306_bib179","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","article-title":"Ferroptosis: past, present and future","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.clineuro.2022.107306_bib180","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.cell.2019.03.032","article-title":"Selenium drives a transcriptional adaptive program to block ferroptosis and treat stroke","volume":"177","author":"Alim","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.clineuro.2022.107306_bib181","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.brainres.2018.09.012","article-title":"Glutathione peroxidase 4 participates in secondary brain injury through mediating ferroptosis in a rat model of intracerebral hemorrhage","volume":"1701","author":"Zhang","year":"2018","journal-title":"Brain Res."},{"issue":"6","key":"10.1016\/j.clineuro.2022.107306_bib182","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/ana.25356","article-title":"N-acetylcysteine targets 5 lipoxygenase-derived, toxic lipids and can synergize with prostaglandin E2 to inhibit ferroptosis and improve outcomes following hemorrhagic stroke in mice","volume":"84","author":"Karuppagounder","year":"2018","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.clineuro.2022.107306_bib183","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.33549\/physiolres.933601","article-title":"Relation of plasma selenium and lipid peroxidation end products in patients with Alzheimer\u2019s disease","volume":"66","author":"Chmatalova","year":"2017","journal-title":"Physiol. Res."},{"key":"10.1016\/j.clineuro.2022.107306_bib184","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3389\/fnagi.2018.00399","article-title":"N-acetylcysteine prevents the spatial memory deficits and the redox-dependent RyR2 decrease displayed by an Alzheimer\u2019s disease rat model","volume":"10","author":"More","year":"2018","journal-title":"Front. Aging Neurosci."},{"issue":"5","key":"10.1016\/j.clineuro.2022.107306_bib185","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1038\/s41418-020-00685-9","article-title":"Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer\u2019s disease","volume":"28","author":"Bao","year":"2021","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.clineuro.2022.107306_bib186","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/cmi.2014.89","article-title":"NADPH oxidases: an overview from structure to innate immunity-associated pathologies","volume":"12","author":"Panday","year":"2015","journal-title":"Cell Mol. Immunol."},{"issue":"7","key":"10.1016\/j.clineuro.2022.107306_bib187","first-page":"535","article-title":"[Neo-natal chylothorax: antenatal echographic diagnosis and favourable outcome]","volume":"42","author":"Ladreyt","year":"1987","journal-title":"Pediatrie"},{"issue":"10\u201311","key":"10.1016\/j.clineuro.2022.107306_bib188","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.mad.2004.08.009","article-title":"Nuclear factor kappa B activation by NADPH oxidases","volume":"125","author":"Clark","year":"2004","journal-title":"Mech. Ageing Dev."},{"issue":"10","key":"10.1016\/j.clineuro.2022.107306_bib189","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3109\/1061186X.2015.1036276","article-title":"The human Nox4: gene, structure, physiological function and pathological significance","volume":"23","author":"Guo","year":"2015","journal-title":"J. Drug Target"},{"issue":"6","key":"10.1016\/j.clineuro.2022.107306_bib190","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1177\/0271678X15606456","article-title":"Detrimental role of pericyte Nox4 in the acute phase of brain ischemia","volume":"36","author":"Nishimura","year":"2016","journal-title":"J. Cereb. Blood Flow. Metab."},{"issue":"3","key":"10.1016\/j.clineuro.2022.107306_bib191","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.nbd.2011.07.012","article-title":"Cognitive impairment in humanized APPxPS1 mice is linked to Abeta(1-42) and NOX activation","volume":"44","author":"Bruce-Keller","year":"2011","journal-title":"Neurobiol. Dis."},{"issue":"9","key":"10.1016\/j.clineuro.2022.107306_bib192","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000479","article-title":"Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration","volume":"8","author":"Kleinschnitz","year":"2010","journal-title":"PLoS Biol."}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846722001871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846722001871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T19:21:53Z","timestamp":1726514513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846722001871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":192,"alternative-id":["S0303846722001871"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2022.107306","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Shared pathophysiology: Understanding stroke and Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2022.107306","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107306"}}